3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Hematologic Neoplasms
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Melanoma
2
Hematopoietic and Lymphatic System Neoplasm
2
Colorectal Neoplasms
2
COVID-19
2
Breast Neoplasms
2
Urologic Neoplasms
1
Urologic Diseases
1
Spondylitis, Ankylosing
1
Psoriasis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Malignant Solid Neoplasm
1
Lupus Erythematosus, Systemic
1
Inflammatory Bowel Diseases
1
Hypogonadism
1
Head and Neck Neoplasms
1
HIV Infections
1
Death
1
Crohn Disease
1
Colitis, Ulcerative
1
Carcinoma, Renal Cell
1
Bilateral Breast Carcinoma
1
Autoimmune Diseases
1
Interventions
Cyclophosphamide
7
Mycophenolic Acid
5
Whole-Body Irradiation
4
Busulfan
4
fludarabine phosphate
3
fludarabine
3
Tacrolimus
3
Rituximab
3
Prednisone
3
Methotrexate
3
Inotuzumab Ozogamicin
3
Etoposide
3
Cytarabine
3
Cyclosporine
3
venetoclax
2
ruxolitinib
2
pegfilgrastim
2
asciminib
2
Vincristine
2
Peripheral Blood Stem Cell Transplantation
2
Mercaptopurine
2
Filgrastim
2
Dexamethasone
2
Calcium Dobesilate
2
tocilizumab
1
ricolinostat
1
rasburicase
1
ponatinib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor, human
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
Practice Guidelines as Topic
×
30 days
×
Clear all
No trials found.